क्यूआर कोड

Pazopanib in the treatment of advanced renal cell carcinoma

Pazopanib is an oral multitargeted tyrozine kinase inhibitor that is used in advanced renal cancer in most countries of the world. Pazopanib inhibits tyrosine kinase receptors involved in tumor angiogenesis and proliferation, including VEGF, platelet-derived growth factor (PDGF) and stem cell growth...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: M. I. Volkova, A. S. Olshanskaya
स्वरूप: Artigo
भाषा:Russo
प्रकाशित: Remedium Group LLC 2018-11-01
श्रृंखला:Медицинский совет
विषय:
pazopanib
sorafenib
sunitinib
axitinib
bevacizumab
everolimus
disseminated renal cell carcinoma
targeted therapy
survival
ऑनलाइन पहुंच:https://www.med-sovet.pro/jour/article/view/2753
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन